China’s State FDA To Commence Drug Re-registration

China's State FDA will begin re-registering drugs according to drug approval number to set up a comprehensive, authentic and reliable database. At the same time, the watchdog body aims to speed up the assessment of some backlogged 220,000 drugs that require reregistration under the newly implemented Drug Registration Regulation. The exercise seeks to use a regulated, structured administrative and technical methodology to weed out products that do not conform with required standards of production, safety and composition. Currently, many companies in China hold over 100 permits each but only produce about 20 drugs. (Click here for more - Chinese Language)